Houston Methodist Cancer Center is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Houston Methodist Cancer Center has participated in 43 clinical trials with 18 currently active.
Therapeutic areas: Colorectal Adenocarcinoma, Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8.
Sponsors: M.D. Anderson Cancer Center, Celldex Therapeutics, The Methodist Hospital Research Institute.
Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Houston Methodist Cancer Center has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Houston Methodist Cancer Center has 43 clinical trials on record, with 18 currently active. Their work covers Colorectal Adenocarcinoma, Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8.
Yes — Houston Methodist Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.